Evaluation of the Tolerability of Switching Patients on Chronic Full μ-Opioid Agonist Therapy to Buccal BuprenorphineLynn R. Webster, A. L. Finn, Daniel Gruener et al.|Pain Medicine|2016Cited by 32
Safety, Pharmacokinetics and Pharmacodynamics of the Oral Toll-Like Receptor 7 Agonist GS-9620 in Treatment-Naive Patients with Chronic Hepatitis CEric Lawitz, M. Rodríguez‐Torres, Lynn R. Webster et al.|Antiviral Therapy|2014Cited by 30
A randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4Bradley Vince, Xiao-Jian Zhou, John M. Hill et al.|Journal of Hepatology|2014Cited by 23
1188 GS-6620, A LIVER-TARGETED NUCLEOTIDE PRODRUG, EXHIBITS ANTIVIRAL ACTIVITY AND FAVORABLE SAFETY PROFILE OVER 5 DAYS IN TREATMENT NAIVE CHRONIC HCV GENOTYPE 1 SUBJECTSE.J. Lawitz, M. Rodríguez‐Torres, Jacqueline Hill et al.|Journal of Hepatology|2012Cited by 11